Last reviewed · How we verify

NCT06019195

The Effect of Intermittent Fasting on Brain Health

Completed NA Last updated 6 February 2026
What this trial tests

NA trial testing Time restricted eating in Intermittent Fasting in 32 participants. Completed in 2 February 2026.

Timeline
13 May 2024
Primary endpoint
2 February 2026
2 February 2026

Quick facts

Lead sponsorUniversity of Oklahoma
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment32
Start date13 May 2024
Primary completion2 February 2026
Estimated completion2 February 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Oklahoma

Who can join

Adults 55 to 80, any sex, with Intermittent Fasting or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The central hypothesis of this study is that closer adherence to time restricted eating (TRE) will improve endothelial function, neurovascular (NVC) responses, resulting in improved cognitive performance, potentially through activation of SIRT1-dependent vasoprotective pathways.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Time restricted eating

Trials testing the same drug.

Other recruiting trials for Intermittent Fasting

Currently open trials in the same condition.

Other University of Oklahoma trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06019195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing